Last reviewed · How we verify
NCT07017855: STAR-4VT
Stereotactic Radiosurgery as Second-line Therapy for Ventricular Tachycardia
NA trial testing Stereotactic Arrhythmia Radioablation (STAR) in Ventricular Tachycardia, Monomorphic in 150 participants. Not yet recruiting.
1 May 2027
Quick facts
| Lead sponsor | Medical University of Silesia |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 1 July 2025 |
| Primary completion | 1 May 2027 |
| Estimated completion | 1 November 2028 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Stereotactic Arrhythmia Radioablation (STAR)
- Catheter Ablation
Conditions studied
- Ventricular Tachycardia, Monomorphic — all drugs for Ventricular Tachycardia, Monomorphic →
- Ventricular Tachycardia, Sustained — all drugs for Ventricular Tachycardia, Sustained →
- Ventricular Tachycardia (VT) — all drugs for Ventricular Tachycardia (VT) →
- Ventricular Tachycardia (V-Tach) — all drugs for Ventricular Tachycardia (V-Tach) →
Sponsor
Medical University of Silesia
Who can join
18 and older, any sex, with Ventricular Tachycardia, Monomorphic or Ventricular Tachycardia, Sustained. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to compare the efficacy and safety of treating recurrent sustained Ventricular Tachycardia (sVT) after prior Catheter Ablation (CA) in patients with Implanted Cardioverter-Defibrillator (ICD) between re-do of conventional endocardial CA and Stereotactic Arrhythmia Radioablation (STAR).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07017855
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Medical University of Silesia trials
Trials by the same sponsor.
- NCT06212674 — Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients · Phase 4 · recruiting
- NCT06970002 — Respiratory Stabilization in Chronic Acidosis Before Bronchofiberoscopy & Non-Invasive Ventilation Effectivenes · NA · not yet recruiting
- NCT07137299 — POPQ Associated With Total Laparoscopic Hysterectomy · not yet recruiting
- NCT06970041 — To Assess the Types of Mechanical Ventilation in Enabling Therapeutic Bronchofiberoscopy in Patients With Decompensated · NA · not yet recruiting
- NCT07120529 — Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective M · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07017855 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Silesia
- Last refreshed: 12 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07017855.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing